Table of Contents: CATIE TreatmentUpdate

Table of Contents: CATIE TreatmentUpdate - 2005

Canadian AIDS Treatment Information Exchange
Edited by: Sean Hosein

TreatmentUpdate 153: December - Vol. 17, No. 7: I SIDE EFFECTS AND COMPLICATIONS: A. Hope for healthier hearts; I SIDE EFFECTS AND COMPLICATIONS: B. Does switching therapy away from d4T help the face?; I SIDE EFFECTS AND COMPLICATIONS: C. Creatine flunks a test; I SIDE EFFECTS AND COMPLICATIONS: D. Uridine finally gets tested in people; I SIDE EFFECTS AND COMPLICATIONS: E. Uridine—effect on the liver and depression; I SIDE EFFECTS AND COMPLICATIONS: F. Extended-release high-dose niacin helps lower lipid levels; I SIDE EFFECTS AND COMPLICATIONS: G. Dying bones found in a small proportion of PHAs; I SIDE EFFECTS AND COMPLICATIONS: H. Italian study explores reasons for sexual dysfunction in men; I SIDE EFFECTS AND COMPLICATIONS: I. Swedes compare treatment switching with interruption; I SIDE EFFECTS AND COMPLICATIONS: J. Can statins help reverse body-shape changes in men?
TreatmentUpdate 152: October/November - Vol. 17, No. 6: I ANTI-HIV AGENTS: A. Still searching for a cure; I ANTI-HIV AGENTS: B. Overcoming barriers to a cure; I ANTI-HIV AGENTS: C. Can valproic acid help flush HIV from hiding?; I ANTI-HIV AGENTS: D. Valproic acid and HIV eradication—many questions remain; I ANTI-HIV AGENTS: E. Canadian trial of valproic acid; I ANTI-HIV AGENTS: F. Study finds PEP not 100% effective in preventing HIV infection
TreatmentUpdate 151: August/September - Vol. 17, No. 5: I ANTI-HIV AGENTS: A. Coming soon: new protease inhibitors; B. TMC114—an overview; C. Interactions with TMC114; D. What the future holds for TMC114; E. Kaletra and Meltrex update; F. Kaletra + atazanavir; G. Dueling nukes: AZT + 3TC vs. tenofovir + FTC; H. Continuing or stopping 3TC; I. Abacavir once or twice daily; J. T-20 shows long-term effectiveness and safety; K. Needle-free T-20; L. Is FOTO a treatment interruption that works?; II SIDE EFFECTS: A. Using metabolomics for predicting side effects
TreatmentUpdate 150: June/July - Vol. 16, No. 4: I IMMUNE BOOSTERS: Clues to long-term survival may lie in CD91; II WASTING: Anabolic steroid helps women gain weight; III COMPLICATIONS AND SIDE EFFECTS: A. Is it Age or AIDS?; III COMPLICATIONS AND SIDE EFFECTS: B. Concerns about statins; III COMPLICATIONS AND SIDE EFFECTS: C. Comparing the safety of statins; III COMPLICATIONS AND SIDE EFFECTS: D. Crestor tested in PHAs; III COMPLICATIONS AND SIDE EFFECTS: E. Health Canada warns about statin side effects; IV DRUG INTERACTIONS: Rosiglitazone and anti-HIV agents
TreatmentUpdate 149: April/May - Vol. 17, No. 3: 1. INFECTION FIGHTERS: LGV: An old infection resurges; 2. INFECTION FIGHTERS: When germs travel; 3. INFECTION FIGHTERS: Key facts about LGV; 4. INFECTION FIGHTERS: Many questions, no answers; 5. ADDICTIONS: Crystal meth: Understanding its allure; 6. ADDICTIONS: Drug twists brain and body; 7. ADDICTIONS: Sex, lies and crystal;
TreatmentUpdate 148: March - Vol. 17, No. 2: 1. COMPLICATIONS AND SIDE EFFECTS: Alberta clinic saves lives but faces new challenges; 2. COMPLICATIONS AND SIDE EFFECTS: French researchers study bone disease; 3. ADDICTIONS: Crystal meth research; 4. ADDICTIONS: Can an anti-seizure drug assist recovery from cocaine and crystal meth addiction?
TreatmentUpdate 147: January/February - Vol. 17, No. 1: ANTI-HIV AGENTS- 1. Starting therapy — Three vs. four drugs; ANTI-HIV AGENTS- 2. Atazanavir vs. Kaletra; ANTI-HIV AGENTS- 3. Tipranavir in treatment-experienced PHAs; ANTI-HIV AGENTS- 4. T-20 (enfurvirtide, Fuzeon); ANTI-HIV AGENTS- 5. Five-year results from an NNRTI-based regimen; INFECTION FIGHTERS- 1. Hepatitis C and HIV; INFECTION FIGHTERS- 2. Hepatitis C — Some types are worse than others; INFECTION FIGHTERS- 3. Hepatitis C — Is a cure possible?; INFECTION FIGHTERS- 4. Hepatitis C — Response to therapy at 12 weeks is the key to success; VACCINES- 1. Vaccines as therapy; VACCINES- 2. From Brazil and France: A vaccine against HIV may lower viral load; VACCINES- 3. From Israel: a T-cell vaccine; VACCINES- 4. Can vaccines against HPV work in PHAs?
Copyright / Staff / How to Contact

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980,2005. AEGiS . All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of ÆGIS , or the party credited as the provider of the content. Please contact the party credited as the provider of the content for permission to reproduce.

Table Of Contents